iRhythm Technologies, Inc. (NASDAQ:IRTC) Shares Acquired by Blair William & Co. IL


Share on StockTwits

Blair William & Co. IL lifted its stake in shares of iRhythm Technologies, Inc. (NASDAQ:IRTC) by 26.8% during the fourth quarter, according to the company in its most recent filing with the Securities & Exchange Commission. The firm owned 212,608 shares of the company’s stock after purchasing an additional 44,898 shares during the quarter. Blair William & Co. IL’s holdings in iRhythm Technologies were worth $50,433,000 at the end of the most recent quarter.

Other large investors also recently bought and sold shares of the company. Engineers Gate Manager LP purchased a new stake in shares of iRhythm Technologies in the 3rd quarter worth about $1,936,000. WINTON GROUP Ltd purchased a new stake in shares of iRhythm Technologies in the 3rd quarter worth about $3,057,000. California Public Employees Retirement System boosted its position in shares of iRhythm Technologies by 3.6% in the 3rd quarter. California Public Employees Retirement System now owns 62,569 shares of the company’s stock worth $14,898,000 after buying an additional 2,148 shares in the last quarter. Aigen Investment Management LP purchased a new stake in shares of iRhythm Technologies in the 3rd quarter worth about $203,000. Finally, AlphaCrest Capital Management LLC purchased a new stake in shares of iRhythm Technologies in the 3rd quarter worth about $358,000.

Several equities research analysts recently commented on IRTC shares. Truist decreased their price objective on shares of iRhythm Technologies from $265.00 to $220.00 in a research report on Monday, February 1st. Smith Barney Citigroup decreased their price objective on shares of iRhythm Technologies from $275.00 to $238.00 in a research report on Thursday, December 3rd. Citigroup Inc. 3% Minimum Coupon Principal Protected Based Upon Russell decreased their price objective on shares of iRhythm Technologies from $275.00 to $238.00 in a research report on Thursday, December 3rd. Oppenheimer lowered shares of iRhythm Technologies from an “outperform” rating to a “market perform” rating in a report on Tuesday, November 17th. Finally, William Blair restated a “buy” rating on shares of iRhythm Technologies in a report on Thursday, December 10th. One analyst has rated the stock with a sell rating, three have given a hold rating and eight have assigned a buy rating to the company’s stock. iRhythm Technologies presently has an average rating of “Buy” and a consensus target price of $218.77.

In other news, EVP David A. Vort sold 10,000 shares of the stock in a transaction dated Tuesday, December 15th. The shares were sold at an average price of $210.00, for a total transaction of $2,100,000.00. Following the transaction, the executive vice president now directly owns 23,379 shares in the company, valued at approximately $4,909,590. The sale was disclosed in a legal filing with the SEC, which is available at this hyperlink. Also, EVP David A. Vort sold 5,000 shares of the stock in a transaction dated Tuesday, December 29th. The stock was sold at an average price of $239.14, for a total transaction of $1,195,700.00. Following the transaction, the executive vice president now owns 20,602 shares in the company, valued at $4,926,762.28. The disclosure for this sale can be found here. Over the last quarter, insiders have sold 45,000 shares of company stock worth $10,453,750. Insiders own 3.10% of the company’s stock.

Shares of IRTC stock opened at $159.03 on Tuesday. The firm has a market cap of $4.59 billion, a P/E ratio of -83.26 and a beta of 1.68. iRhythm Technologies, Inc. has a 1-year low of $56.54 and a 1-year high of $286.19. The company has a debt-to-equity ratio of 0.07, a current ratio of 6.55 and a quick ratio of 6.46. The firm’s 50-day simple moving average is $208.77 and its 200-day simple moving average is $218.65.

iRhythm Technologies Profile

iRhythm Technologies, Inc, a digital healthcare company, provides ambulatory electrocardiogram (ECG) monitoring products for patients at risk for arrhythmias in the United States. It offers Zio service, an ambulatory cardiac monitoring solution that combines a wire-free, patch-based, and wearable biosensor with a cloud-based data analytic platform to help physicians to monitor patients and diagnose arrhythmias.

Read More: Price Target

Want to see what other hedge funds are holding IRTC? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for iRhythm Technologies, Inc. (NASDAQ:IRTC).

Institutional Ownership by Quarter for iRhythm Technologies (NASDAQ:IRTC)

Receive News & Ratings for iRhythm Technologies Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for iRhythm Technologies and related companies with MarketBeat.com's FREE daily email newsletter.